Smoking and schizophrenia M Šagud, A Mihaljević-Peleš, D Mück-Šeler, N Pivac, B Vuksan-Ćusa, ... Psychiatria Danubina 21 (3), 371-375, 2009 | 170 | 2009 |
The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naive patients with first-episode schizophrenia treated with risperidone N Jovanović, N Božina, M Lovrić, V Medved, M Jakovljević, AM Peleš European journal of clinical pharmacology 66, 1109-1117, 2010 | 116 | 2010 |
The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression D Mück-Šeler, N Pivac, M Šagud, M Jakovljević, A Mihaljević-Peleš Progress in Neuro-Psychopharmacology and Biological Psychiatry 26 (7-8 …, 2002 | 108 | 2002 |
Olanzapine in the treatment‐resistant, combat‐related PTSD–a series of case reports M Jakovljević, M Šagud, A Mihaljević‐Peleš Acta Psychiatrica Scandinavica 107 (5), 394-396, 2003 | 100 | 2003 |
Platelet serotonin and serum cholesterol concentrations in suicidal and non-suicidal male patients with a first episode of psychosis D Marčinko, N Pivac, M Martinac, M Jakovljević, A Mihaljević-Peleš, ... Psychiatry research 150 (1), 105-108, 2007 | 98 | 2007 |
MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression AM Peles, N Bozina, M Sagud, MR Kuzman, M Lovric Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (6), 1439-1444, 2008 | 89 | 2008 |
Gender differences in depression M Šagud, LJ Hotujac, A Mihaljević-Peleš, M Jakovljević Collegium antropologicum 26 (1), 149-157, 2002 | 82 | 2002 |
Smoking in schizophrenia: recent findings about an old problem M Sagud, AM Peles, N Pivac Current opinion in psychiatry 32 (5), 402-408, 2019 | 78 | 2019 |
Cognitive deficit in schizophrenia: an overview A Mihaljević-Peleš, M Bajs Janović, M Šagud, M Živković, Š Janović, ... Psychiatria Danubina 31 (suppl 2), 139-142, 2019 | 78 | 2019 |
Catechol-O-methyl transferase and schizophrenia M Šagud, D Műck-Šeler, A Mihaljević-Peleš, B Vuksan-Ćusa, M Živković, ... Psychiatria Danubina 22 (2), 270-274, 2010 | 74 | 2010 |
Quetiapine augmentation in treatment-resistant depression: a naturalistic study M Šagud, A Mihaljević-Peleš, D Mück-Šeler, M Jakovljević, N Pivac Psychopharmacology 187, 511-514, 2006 | 74 | 2006 |
Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients M Šagud, N Pivac, D Mück-Šeler, M Jakovljević, A Mihaljević-Peleš, ... Neuropsychobiology 45 (3), 139-143, 2002 | 74 | 2002 |
Lipid levels in female patients with affective disorders M Sagud, A Mihaljevic-Peles, N Pivac, M Jakovljevic, D Muck-Seler Psychiatry research 168 (3), 218-221, 2009 | 66 | 2009 |
Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia B Vuksan-Cusa, M Sagud, M Jakovljevic, AM Peles, N Jaksic, ... Nordic journal of psychiatry 67 (5), 320-325, 2013 | 58 | 2013 |
Smoking in schizophrenia: an updated review M Šagud, B Vuksan-Ćusa, N Jakšić, A Mihaljević-Peleš, ... Psychiatria Danubina 30 (suppl. 4), 216-223, 2018 | 57 | 2018 |
Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder N Bozina, A Mihaljevic Peles, M Sagud, H Bilusic, M Jakovljevic The World Journal of Biological Psychiatry 9 (3), 190-197, 2008 | 56 | 2008 |
A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment M Sagud, M Nikolac Perkovic, B Vuksan-Cusa, A Maravic, D Svob Strac, ... Psychopharmacology 233, 3259-3267, 2016 | 53 | 2016 |
Serum brain-derived neurotrophic factor (BDNF): the severity and symptomatic dimensions of depression S Jevtović, D Karlović, A Mihaljević-Peleš, V Šerić, N Vrkić, N Jakšić Psychiatria Danubina 23 (4.), 363-369, 2011 | 52 | 2011 |
Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics B Vuksan-Ćusa, M Jakovljević, M Šagud, AM Peleš, D Marčinko, R Topić, ... Psychiatry research 189 (1), 21-25, 2011 | 51 | 2011 |
The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol M Zivkovic, A Mihaljevic-Peles, N Bozina, M Sagud, M Nikolac-Perkovic, ... Journal of clinical psychopharmacology 33 (5), 593-599, 2013 | 48 | 2013 |